Pharma Journalist 8947 posts 0 comments

SMi Reports: Registration is open for SMi Group’s 12th annual conference and exhibition taking place in January 2020 in London. As Europe’s leading Pre-Filled Syringes conference,…
Read More...

The Neuromuscular Drug Development Summit Returns to Boston in October The 2nd Neuromuscular Drug Development Summit, or NMD, will be held in Boston, MA, from October 23-25, 2019. This…
Read More...

GeneCentric Therapeutics, Inc. announced that it has acquired Select ImmunoGenomics, LLC, a Chapel Hill, NC-based provider of advanced immunogenomic, data analysis and biomarker…
Read More...

Phio Pharmaceuticals Corp. announced that is has entered into a research collaboration with the Helmholtz Zentrum München. The agreement covers the design and development of new targets…
Read More...

Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement (RCA) focused on the use of…
Read More...

The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Calquence (acalabrutinib) as a monotherapy treatment for…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced positive results from the Phase III PAOLA-1 trial in women with…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the European Commission (EC) has approved variations to broaden the use of Imbruvica (ibrutinib) in two…
Read More...

Eli Lilly and Company announced Taltz (ixekizumab) met the primary and all major secondary endpoints up to week 12 in the Phase 4 IXORA-R study, which evaluated the efficacy and safety…
Read More...